查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829818

2025年全球粘膜給藥裝置市場報告

Transmucosal Drug Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，經粘膜給藥裝置市場規模強勁成長，從2024年的502.4億美元增加至2025年的546.3億美元，複合年成長率為8.7%。這段歷史時期的成長可歸因於快速緩解心絞痛的需求、舌下給藥快速吸收進入血液的有效性、避免胃腸道劣化的需求、頰片的開發以及對胜肽和蛋白質非侵入性遞送的需求。

預計未來幾年，粘膜給藥裝置市場規模將強勁成長，到2029年將達到760.6億美元，年複合成長率（CAGR）為8.6%。預測期內的成長可歸因於智慧給藥系統的發展、慢性病發病率的上升、對個人化醫療的日益重視、高用藥需求的老齡化人口以及人們日益增強的醫療意識。預測期內的主要趨勢包括：治療應用的擴展、個人化醫療給藥裝置的客製化、監管批准和指南的製定、新興市場、環保裝置以及創新配方。

粘膜給藥裝置是醫療設備，旨在透過口腔、鼻腔或直腸等黏膜給藥，使其快速吸收進入血液。這類裝置尤其適用於輸送胃腸道吸收不良或需要快速起效的藥物，例如止痛藥或荷爾蒙療法。其主要功能是繞過消化器官系統，提供直接有效的給藥途徑。

粘膜給藥裝置主要分為兩類：粘膜和主動式。被動式粘膜給藥是指藥物無需外部能量或主動轉運機制即可經由粘膜吸收。產品類型包括頰片、口腔噴霧、舌下膜、薄片、凝膠和糖果甜點，用於疼痛管理、成癮治療和荷爾蒙療法等。最終用戶包括學術和研究機構、製藥和生物技術公司、診斷實驗室以及醫院。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，粘膜系列提供粘膜給藥裝置市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的粘膜粘膜裝置細分市場、市場趨勢、商業機會以及在粘膜給藥裝置行業取得成功所需的其他數據。本粘膜給藥裝置市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年8.6%的預測成長率，較我們先前對該市場的預測略有下降0.6%。下降主要源自於美國與其他國家之間關稅的影響。這可能會直接影響美國，導致來自比利時和加拿大等主要地區的生物黏附聚合物薄膜和精密計量泵的供應鏈中斷，從而可能導致速效給藥系統短缺。此外，由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，其影響也將更加廣泛。

預計未來幾年慢性病盛行率的上升將推動粘膜給藥裝置市場的成長。慢性病通常發展緩慢，持續時間長，通常需要持續的醫療管理來控制症狀和預防併發症。慢性病的增加歸因於生活方式的選擇、人口老化、環境影響、醫療保健系統內部的挑戰、都市化等因素。粘膜給藥裝置透過提供可控且高效的藥物輸送來管理慢性病，確保持續的治療水平以控制症狀並提高患者依從性。例如，根據美國非營利組織白血病和淋巴瘤協會 (LLS) 2023 年 8 月的報告，美國大約每三分鐘就會有一人被診斷出患有白血病、淋巴瘤或骨髓瘤。預計 2023 年將診斷出 184,720 例病例，佔當年 1,958,310 例新發癌症病例的 9.4%。因此，慢性病盛行率的上升正在推動粘膜給藥裝置市場的成長。

經粘膜給藥裝置領域的主要企業正在積極尋求創新解決方案，例如專有的經皮吸收貼片給藥平台，旨在改善藥物吸收、增強患者依從性並提供便利性。這些平台利用各自公司的專長技術，透過皮膚給藥，實現控制釋放並最佳化治療效果。例如，2024年1月，美國生物技術公司Starton Therapeutics Inc.推出了一款名為STARSILON的全新專有經皮吸收貼片給藥平台。該平台專門設計用於長時間遞送難以配製的活性藥物成分（API），從而擴展了經皮給藥的選擇，並透過其緩釋性機制增強治療效果。

2023年4月，印度製藥公司Diffgen Pharmaceuticals收購了Aveva Drug Delivery Services，收購金額未揭露。此次策略性收購旨在增強Diffgen Pharmaceuticals的藥物輸送能力，並為其藥品組合注入先進技術。總部位於美國的Aveva Drug Delivery Services專注於生產經皮劑型(TDS)和口腔溶解膜(ODF)。

粘膜給藥裝置市場包括舌下噴霧、滴鼻劑、直腸栓劑和舌下片劑的銷售。此市場的價值是指“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球粘膜給藥裝置：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球粘膜給藥裝置市場：成長率分析
  • 全球粘膜給藥裝置市場表現：規模與成長，2019-2024
  • 全球粘膜給藥裝置市場預測：規模與成長，2024-2029年，2034年
  • 全球粘膜給藥裝置：總目標市場（TAM）

第6章 市場細分

  • 全球粘膜給藥裝置市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 被動經經皮給藥
  • 主動經皮給藥
  • 全球粘膜給藥裝置市場（依藥物類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 頰片
  • 口腔噴霧劑
  • 舌下膜和舌下薄片
  • 凝膠
  • 藥用糖果甜點
  • 其他藥物類型
  • 全球粘膜給藥裝置市場（依適應症、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 疼痛管理
  • 成癮治療
  • 荷爾蒙療法
  • 其他適應症
  • 全球粘膜給藥設備市場（依最終使用者、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 學術研究機構
  • 製藥和生物技術公司
  • 診斷實驗室
  • 醫院
  • 全球粘膜給藥裝置市場：依類型細分：被動經皮給藥、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 水庫系統
  • 矩陣系統
  • 微針系統
  • 壓敏膠黏劑體系
  • 全球粘膜給藥裝置市場：依主動經皮給藥類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 離子電滲
  • 超音波導入
  • 電穿孔
  • 熱消融
  • 微孔化

第7章 區域和國家分析

  • 全球粘膜給藥裝置市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球粘膜給藥裝置市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 粘膜給藥裝置市場：競爭格局
  • 粘膜給藥裝置市場：公司簡介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Novartis AG
  • Becton Dickinson and Company
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Catalent Inc.
  • AptarGroup
  • Glenmark Pharmaceuticals Limited
  • Stevanato Group SpA
  • Lifevision Healthcare Private Limited
  • Noven Pharmaceuticals
  • SAVA Healthcare Limited
  • Antares Pharma Inc.
  • Kaizen Pharmaceuticals Pvt. Ltd.
  • Lucky Pharma Pvt. Ltd.
  • Maya Biotech Pvt. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年粘膜給藥裝置市場：提供新機會的國家
  • 2029年粘膜給藥設備市場：細分市場帶來新機會
  • 2029年粘膜給藥裝置市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31415u

Transmucosal drug delivery devices are medical instruments designed to administer drugs through mucous membranes, such as those found in the mouth, nose, or rectum, allowing for rapid absorption into the bloodstream. These devices are particularly useful for delivering medications that are poorly absorbed by the gastrointestinal tract or require swift onset of action, such as pain relief or hormone therapy. Their primary function is to circumvent the digestive system, offering a direct and efficient route for drug delivery.

The two main categories of transmucosal drug delivery devices are passive transmucosal drug delivery and active transmucosal drug delivery. Passive transmucosal drug delivery involves the absorption of drugs through mucous membranes without external energy or active transport mechanisms. Various types of products include buccal tablets, oral sprays, sublingual films, wafers, gels, medicated confectionery, among others, used for treating conditions such as pain management, addiction, and hormonal therapies. End users include academic and research institutions, pharmaceutical and biotechnology firms, diagnostic laboratories, and hospitals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The transmucosal drug delivery devices research report is one of a series of new reports from The Business Research Company that provides transmucosal drug delivery devices market statistics, including the transmucosal drug delivery devices industry's global market size, regional shares, competitors with a transmucosal drug delivery devices market share, detailed transmucosal drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the transmucosal drug delivery devices industry. This transmucosal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transmucosal drug delivery devices market size has grown strongly in recent years. It will grow from $50.24 billion in 2024 to $54.63 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the need for rapid relief from angina, the effectiveness of sublingual delivery for quick absorption into the bloodstream, desire to bypass gastrointestinal degradation, development of buccal tablets, the need for non-invasive delivery of peptides and proteins.

The transmucosal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $76.06 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the development of smart drug delivery systems, increased prevalence of chronic diseases, growing focus on personalized medicine, aging population with higher medication needs, and increased awareness. Major trends in the forecast period include expansion in therapeutic applications, customizing drug delivery devices for personalized medicine, regulatory approvals and guidelines, emerging markets, eco-friendly devices, and innovative formulations.

The forecast of 8.6% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for bioadhesive polymer films and precision dosing pumps, sourced from key regions such as Belgium and Canada, could lead to shortages in rapid-acting medication systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is expected to drive the growth of the transmucosal drug delivery devices market in the coming years. Chronic diseases are long-lasting conditions that typically develop gradually and persist over time, often requiring ongoing medical management to control symptoms and prevent complications. The rise in chronic diseases can be attributed to factors such as lifestyle choices, aging populations, environmental influences, challenges within healthcare systems, and urbanization. Transmucosal drug delivery devices are employed in managing chronic diseases by providing controlled and efficient medication delivery, ensuring sustained therapeutic levels to manage symptoms and enhance patient adherence. For example, in August 2023, a report from the Leukemia & Lymphoma Society (LLS), a US-based nonprofit organization, indicated that in the US, a person is diagnosed with leukemia, lymphoma, or myeloma approximately every three minutes. In 2023, an estimated 184,720 individuals were expected to be diagnosed, accounting for 9.4% of the projected 1,958,310 new cancer cases for the year. Therefore, the rising prevalence of chronic diseases is fueling the growth of the transmucosal drug delivery devices market.

Leading companies in the transmucosal drug delivery devices sector are actively pursuing innovative solutions such as proprietary transdermal patch delivery platforms, which are designed to improve drug absorption, enhance patient compliance, and offer convenience. These platforms utilize specialized technologies owned by companies to administer medications through the skin, ensuring controlled release and optimized therapeutic outcomes. For example, in January 2024, Starton Therapeutics Inc., a US-based biotechnology firm, introduced STARSILON, a novel proprietary transdermal patch delivery platform. This platform is specifically designed to deliver difficult-to-formulate active pharmaceutical ingredients (APIs) over an extended period, thereby expanding the options for transdermal drug delivery and enhancing therapeutic efficacy through sustained release mechanisms.

In April 2023, Difgen Pharmaceuticals, an India-based pharmaceutical company, acquired Aveva Drug Delivery Services for an undisclosed sum. This strategic acquisition is intended to bolster Difgen Pharmaceuticals' drug delivery capabilities and incorporate advanced technologies into its pharmaceutical product portfolio. Aveva Drug Delivery Services, based in the US, specializes in manufacturing transdermal delivery systems (TDS) and oral dissolvable films (ODF).

Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.

North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transmucosal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transmucosal drug delivery devices market consists of sales of sublingual sprays, nasal drops, rectal suppositories, and sublingual tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transmucosal Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transmucosal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transmucosal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transmucosal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Passive Transdermal Drug Delivery; Active Transdermal Drug Delivery
  • 2) By Drug Type: Buccal Tablets; Oral Sprays; Sublingual Films And Wafers; Gels; Medicated Confectionery; Other Drug Types
  • 3) By Indication: Pain Management; Addiction Treatment; Hormonal Therapies; Others Indications
  • 4) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Hospitals
  • Subsegments:
  • 1) By Passive Transdermal Drug Delivery: Reservoir Systems; Matrix Systems; Micro-Needle Systems; Pressure-Sensitive Adhesive Systems
  • 2) By Active Transdermal Drug Delivery: Iontophoresis; Sonophoresis; Electroporation; Thermal Ablation; Microporation
  • Companies Mentioned: Johnson & Johnson; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company; Abbott Laboratories; Novartis AG; Becton Dickinson and Company; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Catalent Inc.; AptarGroup; Glenmark Pharmaceuticals Limited; Stevanato Group S.p.A; Lifevision Healthcare Private Limited; Noven Pharmaceuticals; SAVA Healthcare Limited; Antares Pharma Inc.; Kaizen Pharmaceuticals Pvt. Ltd.; Lucky Pharma Pvt. Ltd.; Maya Biotech Pvt. Ltd; AdvaCare Pharma LLP; Satsuma Pharmaceuticals Inc.; Biophar Lifesciences Private Limited; Fibovil Pharmaceuticals Private Limited; Slan Medicinal Holdings Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transmucosal Drug Delivery Devices Market Characteristics

3. Transmucosal Drug Delivery Devices Market Trends And Strategies

4. Transmucosal Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Transmucosal Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Transmucosal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Transmucosal Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Transmucosal Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Transmucosal Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Transmucosal Drug Delivery Devices Total Addressable Market (TAM)

6. Transmucosal Drug Delivery Devices Market Segmentation

  • 6.1. Global Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Passive Transdermal Drug Delivery
  • Active Transdermal Drug Delivery
  • 6.2. Global Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Buccal Tablets
  • Oral Sprays
  • Sublingual Films And Wafers
  • Gels
  • Medicated Confectionery
  • Other Drug Types
  • 6.3. Global Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Addiction Treatment
  • Hormonal Therapies
  • Other Indications
  • 6.4. Global Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Diagnostic Laboratories
  • Hospitals
  • 6.5. Global Transmucosal Drug Delivery Devices Market, Sub-Segmentation Of Passive Transdermal Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reservoir Systems
  • Matrix Systems
  • Micro-Needle Systems
  • Pressure-Sensitive Adhesive Systems
  • 6.6. Global Transmucosal Drug Delivery Devices Market, Sub-Segmentation Of Active Transdermal Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Iontophoresis
  • Sonophoresis
  • Electroporation
  • Thermal Ablation
  • Microporation

7. Transmucosal Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Transmucosal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Transmucosal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transmucosal Drug Delivery Devices Market

  • 8.1. Asia-Pacific Transmucosal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transmucosal Drug Delivery Devices Market

  • 9.1. China Transmucosal Drug Delivery Devices Market Overview
  • 9.2. China Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transmucosal Drug Delivery Devices Market

  • 10.1. India Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transmucosal Drug Delivery Devices Market

  • 11.1. Japan Transmucosal Drug Delivery Devices Market Overview
  • 11.2. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transmucosal Drug Delivery Devices Market

  • 12.1. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transmucosal Drug Delivery Devices Market

  • 13.1. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transmucosal Drug Delivery Devices Market

  • 14.1. South Korea Transmucosal Drug Delivery Devices Market Overview
  • 14.2. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transmucosal Drug Delivery Devices Market

  • 15.1. Western Europe Transmucosal Drug Delivery Devices Market Overview
  • 15.2. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transmucosal Drug Delivery Devices Market

  • 16.1. UK Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transmucosal Drug Delivery Devices Market

  • 17.1. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transmucosal Drug Delivery Devices Market

  • 18.1. France Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transmucosal Drug Delivery Devices Market

  • 19.1. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transmucosal Drug Delivery Devices Market

  • 20.1. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transmucosal Drug Delivery Devices Market

  • 21.1. Eastern Europe Transmucosal Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transmucosal Drug Delivery Devices Market

  • 22.1. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transmucosal Drug Delivery Devices Market

  • 23.1. North America Transmucosal Drug Delivery Devices Market Overview
  • 23.2. North America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transmucosal Drug Delivery Devices Market

  • 24.1. USA Transmucosal Drug Delivery Devices Market Overview
  • 24.2. USA Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transmucosal Drug Delivery Devices Market

  • 25.1. Canada Transmucosal Drug Delivery Devices Market Overview
  • 25.2. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transmucosal Drug Delivery Devices Market

  • 26.1. South America Transmucosal Drug Delivery Devices Market Overview
  • 26.2. South America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transmucosal Drug Delivery Devices Market

  • 27.1. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transmucosal Drug Delivery Devices Market

  • 28.1. Middle East Transmucosal Drug Delivery Devices Market Overview
  • 28.2. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transmucosal Drug Delivery Devices Market

  • 29.1. Africa Transmucosal Drug Delivery Devices Market Overview
  • 29.2. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transmucosal Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Transmucosal Drug Delivery Devices Market Competitive Landscape
  • 30.2. Transmucosal Drug Delivery Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Transmucosal Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Becton Dickinson and Company
  • 31.3. Viatris Inc.
  • 31.4. Teva Pharmaceutical Industries Ltd.
  • 31.5. Catalent Inc.
  • 31.6. AptarGroup
  • 31.7. Glenmark Pharmaceuticals Limited
  • 31.8. Stevanato Group S.p.A
  • 31.9. Lifevision Healthcare Private Limited
  • 31.10. Noven Pharmaceuticals
  • 31.11. SAVA Healthcare Limited
  • 31.12. Antares Pharma Inc.
  • 31.13. Kaizen Pharmaceuticals Pvt. Ltd.
  • 31.14. Lucky Pharma Pvt. Ltd.
  • 31.15. Maya Biotech Pvt. Ltd.

32. Global Transmucosal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transmucosal Drug Delivery Devices Market

34. Recent Developments In The Transmucosal Drug Delivery Devices Market

35. Transmucosal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Transmucosal Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Transmucosal Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Transmucosal Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer